Skip to content
PICO Portalanswers from OpenAlex

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

PaperCitations, authors & open-access status

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is a paper indexed in PICO Portal from OpenAlex.

How many citations does Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities have?

PICO Portalcitation count

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has 181 citations in the OpenAlex counts PICO Portal stores.

When was Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities published?

PICO Portalyear

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has 2022 year in the PICO Portal index.

What is the open-access status of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

PICO Portaloa status

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has gold oa status in the PICO Portal index.

What is the DOI of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

PICO Portaldoi

The DOI for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

What is the PMID of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

PICO Portalpmid

The PMID for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

What is the OpenAlex record for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

PICO Portalopenalex

The OpenAlex for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial